Norovirus vaccine: One step closer

Journal of Infectious Diseases

Volumn 211, Issue 6, 2015, Pages 853-855

  Vesikari, Timo ^a   Blazevic, Vesna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NOROVIRUS VACCINE; PLACEBO; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; CROSS REACTION; DIARRHEA; HERD IMMUNITY; HUMAN; NONHUMAN; NOROVIRUS INFECTION; NOTE; PRIORITY JOURNAL; REINFECTION; VIRAL GASTROENTERITIS; VIRUS LIKE AGENT; VOMITING; CALICIVIRIDAE INFECTIONS; FEMALE; GASTROENTERITIS; IMMUNOLOGY; MALE; NOROVIRUS;

CALICIVIRIDAE INFECTIONS; FEMALE; GASTROENTERITIS; HUMANS; IMMUNITY, HERD; MALE; NOROVIRUS;

EID: 84924365505     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu498     Document Type: Note

References (15)

1. Patel MM, Widdowson MA, Glass RI, Akazava K, Vinjé J, Parashar UD. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224-31
2. Lopman BA, Hall AJ, Currs AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011; 52:466-72
3. Payen DC, Vinjé J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121-30
4. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972; 10:1075-81
5. Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 1992; 66:6527-32
6. El-Kamary SS, Pasetti MF, Mendelman PM, et al. Adjuvanted intranasal Norwalk viruslike particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010; 202:1649-58
7. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011; 365:2178-87
8. Vesikari T. Rotavirus vaccine: a concise review. Clin Microbiol Infect 2012; 18(suppl 5):57-63
9. Huhti L, Blazevic V, Puustinen L, Hemming M, Salminen M, Vesikari T. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013. Infect Genet Evol 2014; 26:65-71
10. Malm M, Uusi-Kerttula H, Vesikari T, Blazevic V. High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children. J Infect Dis 2014; 210:1755-62
11. Blazevic V, Lappalainen S, Nurminen K, Huhti L, , Vesikari T. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine 2011; 29:8126-33
12. Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013; 8:e70409
13. Velasquez LS, Shira S, Berta AN, et al. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 2011; 29:5221-31
14. Fang H, Tan M, Xia M, Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 2013; 8:e63269
15. Tan M, Huang P, Xia M, et al. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011; 85:753-64